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ABSTRACT
Ovarian cancer has the highest mortality rate of all gynecologic cancers as 62% of cases are diagnosed at an 
advanced stage. The main concern in the surgical management of ovarian cancer is to achieve optimal cy-
toreductive surgery. Effective cytoreductive surgery at the time of initial therapy has been identified as the 
most important prognostic factor in the management of advanced ovarian cancer. This aggressive approach 
can cause unusual surgical management modalities including diaphragm stripping/resection, bowel resec-
tion, hepatic resection and splenectomy. Thus, splenectomy occasionally happens to be part of the ovarian 
cancer surgery.
The indications and technique of splenectomy and distal pancreatectomy as cytoreductive procedures in 
ovarian cancer patients  were  described.  The authors have  presented the indications and techniques of sple-
nectomy and distal pancreatectomy as cytoreductive procedures in ovarian cancer patients. Intraoperative 
and postoperative complications were reported in this study. 
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INTRODUCTION
Splenectomy with or without distal pancreatec-
tomy is part of cytoreductive surgery, which is used 
in the treatment of advanced and recurrent ovarian 
cancer in order to achieve complete cytoreduction.
The indications for splenectomy are:
a) direct involvement of metastatic omentum 
(omental cake) or peritoneal metastasis (in left hemi-
diaphragm) – in more than 80% of the cases with ad-
vanced cancer or recurrent ovarian cancer
b) solitary or parenchymal splenic metastases 
(rarely)
c) Iatrogenic injury of the spleen during mobili-
zation of the surrounding tissues.
The spleen is involved by metastases in part of 
the omentum after incomplete omentectomy (infra-
colic) (1). Manci (2006) reported 24 patients with in-
volvement of the spleen: the hilum was affected in 
12 and 12 had metastases on the surface or paren-
chyma (1). Splenectomy did not lead to the increase 
of early postoperative morbidity and according to 
the authors this procedure is safe as part of cyto-
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SURGICAL TECHNIQUE
There are two main steps when performing 
splenectomy:
1. The mobilization of the spleno-pancreatic com-
plex. It consists of liberation (ligation and trans-
action) of the gastrocolic and gastrolienal liga-
ment, which are part of the great omentum and 
the splenocolic and phrenocolic ligament, as 
well. Mobilization and supracolic omentectomy 
are performed simultaneously (Fig. 4).
2. Separating the spleen from the pancreatic tail 
or its transection (distal pancreatectomy) and 
ligation of lienal artery and vein. 
Two approaches are used: ventral (the separa-
tion is performed from the visceral surface of the 
spleen) and dorsal – from its parietal surface (Fig. 5, 
Fig. 6).
During the ventral approach there is a risk of 
damage of the pancreas and conditions for postop-
erative pancreatic fistula and this approach should 
be performed only in cases with hilar pancreatic me-
tastases which involve the pancreatic tail and require 
distal pancreatectomy with splenectomy.
In all other conditions without involvement of 
the pancreatic tail, the dorsal approach should be 
performed because it is safe and prevents pancreatic 
fistulas. The dorsal approach has an anatomic blood-
less approach between the tail of pancreas and the li-
enal artery and vein (Fig. 7, Fig. 8). 
After the presenting the lienal vessels they 
are clamped and the spleen is removed with the 
metastases. 
reductive surgery. Otrock (2006) reported 17 cas-
es with solitary metastases in the spleen which oc-
curred between 2 and 10 years after the primary 
treatment, mostly hematogenously (2). According to 
Farrias E (1993) solitary spleen metastases were di-
agnosed by CA-125 elevation and PET/CT. Furu-
kawa (2007) reported excellent survival in cases of 
solitary metastases when surgery and subsequent 
chemotherapy (CT) (Platinum) were applied (3,4). 
Intraoperative splenic injures are the third rea-
son, mainly in emergency splenectomy. They usual-
ly occur after pulling anatomical structures (most-
ly omentum or flexura lienalis of colon transver-
sum), which form dense adhesions with the spleen. 
Fig. 1, 2 and 3 demonstrate the main indications for 
splenectomy.
Fig. 1. Direct involvement of metastatic omentum (Y. Kor-
novski and co-authors)
Fig. 2. Solitary metastases (Y. Kornovski and co-authors)
Fig. 3. Hilar splenic tumor infiltration (Y. Kornovski and 
co-authors)
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The clamping is carried out at distance of the 
hilum of the spleen where there are many lienal 
branches that may cause unnecessary bleeding.
PATIENTS’ CHARACTERISTICS 
Between November, 2014 and February, 2015 
(3 months) in the Gynecological Clinic of MHAT 
St.Anna, Varna during cytoreductive surgeries - 9 
splenectomies and 1 distal pancreatectomy were per-
formed. The distribution by stage was: 8 - IIIC FIGO 
stage and 1 - IV stage. The types of cytoreductive 
surgeries are: interval (after neoadjuvant chemother-
apy) - in 3 patients, secondary - in 2 patients, recur-
rent ovarian cancer - 1 patient and during primary 
surgery - in 3 patients. According to the extent of sur-
Fig. 4. Spleen and pancreas after mobilization (Y. Kor-
novski and co-authors)
Fig. 5. Ventral approach (Y. Kornovski and co-authors)
Fig. 6. Dorsal approach (Y. Kornovski and co-authors)
Fig. 7. Sparing the pancreatic tail 
Fig. 8. Presenting lienal artery and vein (Y. Kornovski and 
co-authors)
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gery: splenectomy and supracolic omentectomy was 
performed in 8 patients; in 1- splenectomy and dis-
tal pancreatectomy; in 2- stripping of the left dia-
phragm. Intraoperative complications occurred in 1 
patient - lesion of the left hemidiaphragm which was 
sutured with continuous stitch. Postoperative com-
plications were observed in two patients: 1 – exces-
sive hypoproteinaemia and mild acute renal failure 
and 1 - mesenteric thrombosis (on the 6th postoper-
ative day).
The hospital stay was 8 days, intraoperative 
blood loss - minimal and the time of splenectomy-45 
min (mobilization - 30min., spleen – pancreatic sep-
aration or pancreatic tail resection -15 min.)
Patients’ outcome – 1 patient died after mesen-
teric thrombosis, 1- patients with chylous ascites af-
ter distal pancreatectomy, other patients were alive 
until June 2016. 
DISCUSSION
Eisenkop SM, (2006) compares 47 cases with 
splenectomy and 307 cases without splenectomy at 
the time of primary cytoreductive surgery. 
Splenectomy was associated with more ad-
vanced stage and more extensive surgery. Accord-
ing to the author splenectomy leads to better surviv-
al rate when a complete cytoreduction was achieved; 
does not increase postoperative complications and it 
is associated with longer operative time. The proce-
dure does not change blood loss and hospital stay (4). 
Magtibay (2006) reported 66 cases of splenec-
tomy during primary cytoreduction without compli-
cations (5).
The resection of a part of the pancreatic tail 
with splenectomy increases the risk of complications, 
mostly pancreatic fistulas. 
Yildirim Y. (2005) performed resection of the 
tail of the pancreas in patients with pancreatic me-
tastases in 6% of the cases with advanced ovarian 
cancer, and the procedure led to complete cytoreduc-
tion and acceptable morbidity (6). 
Kehoe SM (2009) presented 17 cases with distal 
pancreatectomy and the rate of complication was 
24% (pancreatic leakage) (7).
CONCLUSIONS
1. The indication for splenectomy, as a part of cy-
toreductive surgery, is primary advanced and 
recurrent ovarian cancer.
2. Splenectomy (with or without distal pancre-
atectomy) increases the operative time, does 
not change the blood loss and the postoperative 
morbidity.
3. Splenectomy is associated with better survival 
rate when complete cytoreduction is achieved. 
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